David Bajor, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer (NCT03699319) | David Bajor, MD | 2018-12-07 |
| CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer (NCT02861300) | David Bajor, MD | 2016-09-12 |
Track David Bajor, MD automatically
Every clearance here is in the API, with alerts when new ones post.